Delivery Order SPE2DB25D3017-SPE2DB25FVJMF
Award Date
6/17/25
Potential Completion Date
6/18/25
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,973.88 firm fixed-price delivery order is for the drug GRALISE ER 600 MG TABLET 90S and has a completion date of May 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,220.39 firm fixed price delivery order is for the provision of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, to be delivered by February 26, 2024. This award is part of a larger indefinite delivery contract (IDC) valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,802.81, is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award with the ID SPE2DX15D3015|SPE2DX24F0EZ0 was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $8,362.39 firm fixed-price delivery order is for GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,189.30, is a firm fixed-price delivery order for the provision of 4564931397 GRALISE ER 300 MG TABLET 90S. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $9,644.86, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of the pharmaceutical product GRALISE ER 600 MG TABLET 90S. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,709.78, is a firm fixed-price Delivery Order for the medical product GRALISE ER 600 MG TABLET 90S. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,783.79, is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 15, 2023. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,627.35 firm fixed-price contract is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of August 10, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The federal contract award summarized in the provided information was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,803.80 Firm Fixed Price Delivery Order contract, with a completion date of February 4, 2025, is for the supply of GRALISE ER 600 MG TABLET 90S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...